BridgeBio Pharma, Inc. (BBIO)

Typically moves ±4.10% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-10-16 APPROXIMATE

BridgeBio Pharma, Inc. (BBIO) has reported earnings 28 times since Dec 26, 2019. The stock moves an average of ±4.10% the day after reporting, closing higher 50.0% of the time. Its largest post-earnings gain was +12.12% (Aug 04, 2022) and its largest decline was -14.33% (Dec 26, 2019). The next earnings report is predicted for 2026-10-16 (approximate).

Earnings reactions

How BBIO moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±4.10%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 10, 2026	☽ POST	-1.12%	open_in_new
May 07, 2026	☽ POST	+0.09%	open_in_new
Feb 24, 2026	☽ POST	-2.59%	open_in_new
Oct 29, 2025	☽ POST	-4.88%	open_in_new
Aug 05, 2025	☽ POST	-8.94%	open_in_new
Apr 29, 2025	☽ POST	+5.33%	open_in_new
Feb 20, 2025	☀ PRE	+1.42%	open_in_new
Nov 12, 2024	☀ PRE	-5.74%	open_in_new
Aug 01, 2024	☀ PRE	+0.89%	open_in_new
May 02, 2024	☀ PRE	+2.63%	open_in_new
Feb 22, 2024	☀ PRE	-1.64%	open_in_new
Nov 02, 2023	☀ PRE	+1.01%	open_in_new
Aug 03, 2023	☀ PRE	+0.31%	open_in_new
May 04, 2023	☀ PRE	-6.25%	open_in_new
Feb 23, 2023	☀ PRE	-4.58%	open_in_new
Nov 03, 2022	☽ POST	-0.2%	open_in_new
Aug 04, 2022	☽ POST	+12.12%	open_in_new
May 10, 2022	☽ POST	-13.88%	open_in_new
Feb 24, 2022	☀ PRE	+8.99%	open_in_new
Nov 04, 2021	☀ PRE	+2.9%	open_in_new
Aug 13, 2021	☽ POST	-1.28%	open_in_new
May 14, 2021	☽ POST	+0.88%	open_in_new
Feb 26, 2021	☀ PRE	+8.52%	open_in_new
Nov 05, 2020	☀ PRE	+2.42%	open_in_new
Aug 11, 2020	☀ PRE	-0.32%	open_in_new
May 13, 2020	☽ POST	-0.58%	open_in_new
Mar 02, 2020	☀ PRE	+1.04%	open_in_new
Dec 26, 2019	☽ POST	-14.33%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.10%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 40 →

Funds holding

$4480945962

Total value held

Buying

28 added · 12 reduced

Janus Henderson Group Plc

$978607712 NEW BUY

Blackrock, Inc.

$823847068 -16.54%

Ubs Group Ag

$421105676 NEW BUY

State Street Corp

$402685485 +33.10%

Invesco Ltd.

$324828265 NEW BUY

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
8-K	20260831	open_in_new SEC.gov
4	20260820	open_in_new SEC.gov
144	20260819	open_in_new SEC.gov
144	20260818	open_in_new SEC.gov
4	20260818	open_in_new SEC.gov
4	20260818	open_in_new SEC.gov
4	20260818	open_in_new SEC.gov
144	20260817	open_in_new SEC.gov
8-K	20260817	open_in_new SEC.gov
SCHEDULE 13D/A	20260817	open_in_new SEC.gov

Frequently asked about BBIO earnings

When does BridgeBio Pharma, Inc. report earnings next? expand_more

BridgeBio Pharma, Inc. (BBIO)'s next earnings date is approximate for 2026-10-16. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does BBIO stock move after earnings? expand_more

Over 28 reports, BBIO has moved an average of ±4.10% the session after earnings, closing higher 50.0% of the time.

What was BBIO's biggest post-earnings move? expand_more

BBIO's largest post-earnings gain on record was +12.12% on Aug 04, 2022, and its largest decline was -14.33% on Dec 26, 2019.

Where can I find BridgeBio Pharma, Inc.'s SEC filings? expand_more

All of BridgeBio Pharma, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.